Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment

Samankaltaisia teoksia

• Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
  Tekijä: Thitinan Aiebchun, et al.
  Julkaistu: (2021-04-01)
• Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
  Tekijä: Utid Suriya, et al.
  Julkaistu: (2022-12-01)
• Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
  Tekijä: Utid Suriya, et al.
  Julkaistu: (2022-07-01)
• Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study
  Tekijä: Duangjai Todsaporn, et al.
  Julkaistu: (2023-03-01)
• Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
  Tekijä: Tasia Amelia, et al.
  Julkaistu: (2022-01-01)